WHO ICTRP trial
Multicentre study to evaluate safety and efficacy of HL217 topical…
EUCTR2019-000642-35-BG · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2019-000642-35-BG |
|---|---|
| Public title | Multicentre study to evaluate safety and efficacy of HL217 topical ophthalmologic solution in the treatment of exudative Age-Related Macular Degeneration |
| Scientific title | A phase IIa randomized, double-blind, multicentre study to evaluate safety and efficacy of HL217 topical ophthalmologic solution in the treatment of exudative Age-Related Macular Degeneration (AMD) |
| Primary sponsor | HANLIM PHARM CO., LTD |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | France;Bulgaria |
| Conditions | AMD (age-related macular degeneration) MedDRA version: 20.0 Level: LLT Classification code 10068530 Term: Macular degeneration progression System Organ Class: 100000004853 ;Therapeutic area: Diseases [C] - Eye Diseases [C11] |
| Interventions | Product Name: HL217 Pharmaceutical Form: Eye drops CAS Number: 571141-49-6 Current Sponsor code: HL217 Concentration unit: mg/ml milligram(s)/millilitre Concentration type: equal Concentration number: 3- Pharmaceutical form of the placebo… |
| Registration date | Aug 16, 2019 |
| Target size | 90 |
| Secondary IDs | HL217-201 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: